← Leaderboards
Derek Michael Dykxhoorn
University Of Miami School Of Medicine
$5,902,943
Attributed
$15,472,731
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,472,731 · 6
By mechanism
U01$6,908,458 · 1
R01$6,236,768 · 2
R33$1,196,817 · 1
P50$764,910 · 1
R21$365,778 · 1
Top collaborators
- Hans Peter Larsson14 shared
- Katja Odening10 shared
- Peter Tieleman10 shared
- Anthony John Griswold5 shared
- Jeffery M. Vance5 shared
- Juan Isaac Young5 shared
- Rene Barro-Soria3 shared
- Chunming Dong3 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Farid Rajabli$4,718,380
- Jeffery M. Vance$28,378,652
- Juan Isaac Young$2,351,277
- Ronald B Goldberg$14,882,436
- Anthony John Griswold$12,295,725
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMolecularFutureInsightPreventionEfficacy TestingStructureVariantPreventResearch PersonnelFamilyAnimal ModelGenesNovel TherapeuticsIn VivoIn VitroInduced Pluripotent Stem CellClinical TrialsCessation Of LifeFunctional RestorationCell TypeGeneticHeartArrhythmia
Grant awards (32)
Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease$1,354,054
U01 · FY2025 · AG
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis$383,750
R01 · FY2025 · HL
Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease$1,381,687
U01 · FY2024 · AG
Polyunsaturated fatty acids as anti-arrhythmic agents.$607,272
R01 · FY2024 · HL
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis$383,750
R01 · FY2024 · HL
Polyunsaturated fatty acids as anti-arrhythmic agents.$62,488
R01 · FY2024 · HL
Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease$1,380,880
U01 · FY2023 · AG
Polyunsaturated fatty acids as anti-arrhythmic agents.$607,272
R01 · FY2023 · HL
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis$383,750
R01 · FY2023 · HL
Polyunsaturated fatty acids as anti-arrhythmic agents.$117,851
R01 · FY2023 · HL
Polyunsaturated fatty acids as anti-arrhythmic agents.$62,488
R01 · FY2023 · HL
Polyunsaturated fatty acids as anti-arrhythmic agents.$58,026
R01 · FY2023 · HL
Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease$1,381,688
U01 · FY2022 · AG
Polyunsaturated fatty acids as anti-arrhythmic agents.$607,272
R01 · FY2022 · HL
Polyunsaturated fatty acids as anti-arrhythmic agents.$112,850
R01 · FY2022 · HL
Polyunsaturated fatty acids as anti-arrhythmic agents.$62,488
R01 · FY2022 · HL
Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease$1,410,149
U01 · FY2021 · AG
Polyunsaturated fatty acids as anti-arrhythmic agents.$644,022
R01 · FY2021 · HL
Polyunsaturated fatty acids as anti-arrhythmic agents$506,770
R01 · FY2019 · HL
Polyunsaturated fatty acids as anti-arrhythmic agents$506,770
R01 · FY2018 · HL
Polyunsaturated fatty acids as anti-arrhythmic agents$558,287
R01 · FY2017 · HL
Polyunsaturated fatty acids as anti-arrhythmic agents$571,662
R01 · FY2016 · HL
TARGETED siRNA DELIVERY AS AN ANTI-HIV MICROBICIDE$406,256
R33 · FY2015 · AI · contact PI
Disease Modeling Core$268,287
P50 · FY2015 · NS · contact PI
TARGETED siRNA DELIVERY AS AN ANTI-HIV MICROBICIDE$405,350
R33 · FY2014 · AI · contact PI
Disease Modeling Core$279,245
P50 · FY2014 · NS · contact PI
TARGETED siRNA DELIVERY AS AN ANTI-HIV MICROBICIDE$385,211
R33 · FY2013 · AI · contact PI
Disease Modeling Core$133,068
P50 · FY2013 · NS · contact PI
Disease Modeling Core$84,309
P50 · FY2012 · NS · contact PI
TARGETED siRNA DELIVERY AS AN ANTI-HIV MICROBICIDE$176,296
R21 · FY2011 · AI · contact PI
Disease Modeling Core$1
P50 · FY2011 · NS · contact PI
TARGETED siRNA DELIVERY AS AN ANTI-HIV MICROBICIDE$189,482
R21 · FY2010 · AI · contact PI